Unknown

Dataset Information

0

Targeting the Mitochondrial Protease ClpP for Anticancer Therapy.


ABSTRACT: Cancer cells depend on mitochondrial reprogramming for growth, but this raises reactive oxygen species (ROS), increasing reliance on protein quality control (PQC) repair mechanisms. The mitochondrial proteome is maintained through a robust PQC composed of chaperones and proteases, including the mitochondrial matrix protease caseinolytic protease P (ClpP). ClpP has recently emerged as a potential therapeutic target against cancer. Notably, imipridones act as ClpP agonists and have shown potent anticancer activity by inhibiting mitochondrial Electron Transport Chain (ETC) function. In this study, we developed a new generation ClpP agonist, compound 9 (MS6076), which exhibits enhanced ClpP binding, more potent disruption of mitochondrial ETC and lethality in breast cancer models compared to the imipridone ONC212. Furthermore, we show that compound 9 induced cell death in cancer cells resistant to ONC212. The discovery and characterization of compound 9 therefore add to the expanding arsenal of imipridones to target ClpP in cancer.

SUBMITTER: Xu Z 

PROVIDER: S-EPMC12700136 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the Mitochondrial Protease ClpP for Anticancer Therapy.

Xu Zhongli Z   Pokushalov Dmitry D   Kabir Md M   Lee Youngeun Y   Chattopadhyay Mrittika M   Jenkins Edmund C EC   Choo Cessarina C   Kaniskan H Ümit HÜ   Germain Doris D   Jin Jian J  

Journal of medicinal chemistry 20251001 20


Cancer cells depend on mitochondrial reprogramming for growth, but this raises reactive oxygen species (ROS), increasing reliance on protein quality control (PQC) repair mechanisms. The mitochondrial proteome is maintained through a robust PQC composed of chaperones and proteases, including the mitochondrial matrix protease caseinolytic protease P (ClpP). ClpP has recently emerged as a potential therapeutic target against cancer. Notably, imipridones act as ClpP agonists and have shown potent an  ...[more]

Similar Datasets

| S-EPMC6528275 | biostudies-literature
2013-07-17 | E-GEOD-40207 | biostudies-arrayexpress
| S-EPMC7547079 | biostudies-literature
2013-07-17 | GSE40207 | GEO
| S-EPMC12036999 | biostudies-literature
2020-02-23 | GSE138894 | GEO
| S-EPMC5836096 | biostudies-literature
| S-EPMC9354705 | biostudies-literature